GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long history ...

GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China, the Piscataway-headquartered company announced May 18. Located in the city of ...

GenScript can synthesize numerous difficult neoantigen peptides and offer specialized optimization tools for specific downstream applications. They have the technical capability and experience to ...

GenScript is best known for its gene synthesis capabilities, which we estimate is more than half of the life science services and products segment. In 2014, GenScript was the leader in gene synthesis, ...

GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, leveraging ...

Traditional DNA synthesis has long been plagued by slow, low-quality results, creating a bottleneck for researchers and impeding progress in both academic and industrial fields; in response, GenScript ...